CADTH launches consultation on real world evidence reporting guidance

10 November 2022 - Today, CADTH, on behalf of the Real World Evidence Steering Committee, launched a public consultation to ...

Read more →

Can we use existing guidance to support the development of robust real world evidence for health technology assessment/payer decision-making?

2 November 2022 - Advances in the digitisation of health systems and expedited regulatory approvals of innovative treatments have led to ...

Read more →

A perspective on life cycle health technology assessment and real world evidence for precision oncology in Canada

25 October 2022 - Health technology assessment can be used to make healthcare systems more equitable and efficient. Advances in precision ...

Read more →

Advancing real world evidence program

19 October 2022 - As announced in the Federal Register notice published on 20 October 2022, the FDA is conducting an ...

Read more →

HARmonized protocol template to enhance reproducibility of hypothesis evaluating real world evidence studies on treatment effects: a good practices report of a joint ISPE/ISPOR Task Force

12 October 2022 - Ambiguity in communication of key study parameters limits the utility of real-world evidence studies in health care ...

Read more →

High quality data to empower data-driven medicines regulation in the European Union

10 October 2022 - EMA and the Heads of Medicines Agencies in the EU Member States are moving ahead with ...

Read more →

NICE recommends NHS collects real world evidence on devices that monitor people with Parkinson’s disease

27 September 2022 - Five promising technologies that could help improve symptoms and quality of life for people with Parkinson’s disease ...

Read more →

FDA finalises guidance on submitting RWD/RWE in application cover letters

13 September 2022 - To help better track submissions that include real world data and real world evidence, the US ...

Read more →

Submitting documents using real world data and real world evidence to FDA for drug and biological products

8 September 2022 - To facilitate FDA’s internal tracking of submissions to the Agency that include real world data and real ...

Read more →

Clinical trials: real world data plays early role in efforts to increase diversity

5 September 2022 - The use of real world data to help design clinical trials is nothing new but increasingly it ...

Read more →

Reproducibility of real world evidence studies using clinical practice data to inform regulatory and coverage decisions

31 August 2022 - Studies that generate real world evidence on the effects of medical products through analysis of digital data ...

Read more →

Real-world data can help expedite drug approvals for serious diseases with few options

10 August 2022 - My grandmother was diagnosed with dementia in the early 2000s. We started taking it seriously when she ...

Read more →

Introducing CADTH’s RWE Guidance Working Group

9 August 2022 - CADTH is pleased to announce the introduction of the Real-World Evidence Guidance Working Group.  ...

Read more →

Connecting electronic health records to clinical trials: how to embrace the promise of real world data

3 August 2022 - We all know that real world data from electronic health records could boost clinical trial efficiency ...

Read more →

Global regulators call for international collaboration to integrate real-world evidence into regulatory decision-making

20 July 2022 - EMA has endorsed a joint statement calling for international collaboration to enable the generation and use ...

Read more →